The city of Tacoma, Washington, currently has 2 active clinical trials seeking participants for COVID19 research studies.
A Study of Baricitinib (LY3009104) in Children With COVID-19
Recruiting
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Gender:
ALL
Ages:
Between 2 years and 18 years
Trial Updated:
04/16/2025
Locations: MultiCare Health System, Tacoma, Washington
Conditions: Covid19, Corona Virus Infection
Long COVID-19 and MAB Study
Recruiting
This study will be observational only. It will provide real-world evidence generated from a representative and large-scale COVID patient base. The adoption, pilot testing and use of NIH PROs among viral tested patients with research purpose on long COVID will be unique and innovative. With the existing and proven scientific rigor, NIH PRO system will be adopted, then modified and tailored to form the long hauler specific, comprehensive instrument, helping generalize future knowledge regarding CO... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/22/2023
Locations: MultiCare Health System, Tacoma, Washington
Conditions: COVID-19